Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Kalia
Effect of Fibrosis on Adverse Events in Patients With Hepatitis C Treated With Telaprevir
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
CPC-107 Pharmacotherapy Follow-Up in Chronic Hepatitis C Patients Treated With Boceprevir or Telaprevir
European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
Evaluation of Persistence of Resistant Variants With Ultra-Deep Pyrosequencing in Chronic Hepatitis C Patients Treated With Telaprevir
PLoS ONE
Multidisciplinary
The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients
Resistance Patterns and Genetic Variations in Patients With Hepatitis C Virus: Emerging Role of Telaprevir
Virus Adaptation and Treatment
Virology
Infectious Diseases
Immunology
Telaprevir in a Patient With Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis
Antiviral Therapy
Infectious Diseases
Pharmacology
Association of Serum Autotaxin Levels With Liver Fibrosis in Patients With Chronic Hepatitis C
Scientific Reports
Multidisciplinary
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Hepatitis C Virus Markers in Patients With Acute Post-Transfusion Hepatitis Treated With Interferon Alfa-2b.
Gut
Gastroenterology
Non-Invasive Fibrosis Assessment Predicts Sustained Virological Response to Telaprevir With Pegylated Interferon and Ribavirin for Chronic Hepatitis C
Antiviral Therapy
Infectious Diseases
Pharmacology
